ABEO - Abeona Therapeutics Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue-8378891,040
Cost of Revenue----
Gross Profit-8378891,040
Operating Expenses
Research Development-16,98910,6554,715
Selling General and Administrative-10,94313,29014,320
Non Recurring----
Others----
Total Operating Expenses-28,67324,77019,586
Operating Income or Loss--27,836-23,881-18,546
Income from Continuing Operations
Total Other Income/Expenses Net-5172,0084,020
Earnings Before Interest and Taxes--27,836-23,881-18,546
Interest Expense--8-6-6
Income Before Tax--27,319-21,873-14,526
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops--27,319-21,873-14,526
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--27,319-21,873-14,526
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--27,319-21,873-14,526